The transfection of human NTera2/D1 teratocarcinoma-derived cell line (or NT2 cells) represents a promising strategy for the delivery of exogenous proteins or biological agents into the central nervous system (CNS). The development of suitable non-viral vectors with high transfection efficiencies requires a profound knowledge of the whole transfection process. In this work, we elaborated and characterized in terms of size and endocytosis (CME) while polyplexes via caveolae-mediated endocytosis (CvME).
INTRODUCTION
Cell therapy is a field that moves rapidly with new cell lines and tissue-engineered constructs developed globally every year. The human NTera2/D1 teratocarcinomaderived cell line (or NT2 cells) can be differentiated into well-characterized populations of neuron-like cells (or NT2-N) that engraft and mature when are transplanted into the adult central nervous system (CNS) of rodents and humans [1] [2] [3] [4] [5] [6] [7] . Moreover, human transplantation studies in the brain of stroke patients demonstrated a lack of tumorigenicity of these cells 6, 8 . On the other hand, the NT2 cells can be used as cellular vehicles with glioma tropism 9 , adding a human cell-based delivery vehicle for clinical glioblastoma therapy, as it was similarly demonstrated for neural stem cells in animal models 10, 11 . Although these features suggest that NT2 cells would be an excellent platform for ex vivo gene therapy in the CNS 3, 7, 9, 12, 13 , the use of non-viral strategies for gene transfer has been scarce 14, 15 .
In the last decade, cationic lipid-mediated 16 and cationic polymer-mediated non-viral gene delivery 17 methods have become useful tools for cellular transfection. Although gene therapy is still dominated by viral vectors, which present higher transfection efficiencies compared to non-viral gene delivery systems, safety issues such as immunogenicity and mutagenicity hinder their clinical applications [18] [19] [20] . At this point, non-viral gene delivery has been the subject of increasing attention due to its relative safety, simple use and easy handling compared to viral vectors 21, 22 . Among lipid based non-viral vectors, liposomes are the most widely used carriers for in vitro and in vivo gene delivery 23 . Lipofectamine 2000 is a commercialized cationic liposome based reagent, which has been extensively used for in vitro gene delivery purposes due to its high transfection efficiency 24 . In addition to liposomes, niosomes (non-ionic surfactant vesicles) have also gained interest as an alternative to liposomes due to their similar structure.
Although the use of these structures has been mainly restricted to drug delivery, our research group has recently obtained some promising results that suggest the possible use of cationic niosomes as non-viral vectors for gene delivery 25, 26 . Finally, among cationic polymers, chitosan is an appropriate candidate for non-viral gene delivery due to its biocompatibility, biodegradability and low cost 27 . Our research group has been working with ultrapure oligochitosan (UOC) obtaining promising results 28, 29 . The non-viral carriers (liposomes, niosomes or polymers) are typically cationic in nature and electrostatically interact with negatively charged DNA molecules forming the so-called lipoplexes, nioplexes and polyplexes, respectively.
Regardless the gene carrier, it is well known that the final gene expression will be highly influenced by the uptake of the non-viral vector, the internalization pathway and, their ability to escape from the endosomes and import the genetic material into the nucleus 30 . At the same time, the internalization route of the vectors will depend on their composition and physicochemical characteristics, such as size, polydispersity, surface charge and morphology 31 . Thus, it is essential to study, specifically, the uptake and intracellular trafficking of each selected non-viral vector, to understand their possible limitations and improve their design.
Therefore, this work was intended to carry out a comparative study of three types of nonviral vectors in human neuronal precursor NT2 cell line. Specifically, we compared lipoplexes based on the commercialized Lipofectamine 2000; nioplexes based on a previously described novel noisome formulation; and polyplexes based on UOCs. For this purpose, the vectors were characterized in terms of size, polydispersity index (PDI) and surface charge. The percentage of transfected cells, mean fluorescent intensity (MFI) and cell viability were analyzed by flow cytometry. Additionally, the expression of the enhanced green fluorescent protein (EGFP) was analyzed by Western Blot. To further explain the differences in the transfection efficiencies that among the three formulations, we performed qualitative and quantitative cellular uptake studies, by confocal microscopy and flow cytometry, respectively, using Cy3 or FITC labeled plasmids. The endocytosis pathways of the studied vectors were determined by colocalization assays and quantified by the Mander´s overlap coefficient. Finally, the endosomal escape was analyzed by simulating the interaction of the vectors with anionic micelles, analogues of endosomal compartment.
MATERIAL AND METHODS

Propagation of pCMS-EGFP
The pCMS-EGFP reporter plasmid was purchased from Plasmid Factory (Bielefeld Germany) and was propagated in Escherichia coli DH5-α and purified using the Qiagen endotoxin-free plasmid purification Maxi prep kit (Qiagen, Santa Clarita, CA, USA)
according to the manufacturer's instructions. The concentration of pDNA was quantified by measuring the absorbance at 260 nm using a NanoDrop® (ND-1000 spectrophotometer, Thermo Fisher Scientific Inc., Denver, USA). The purity of the plasmid was verified by agarose gel electrophoresis in Tris-borate-EDTA buffer, pH 8.0
(TBE buffer). DNA bands were detected using GelRed™ (Biotium, Hayward, California, USA) and images were observed with a ChemiDoc™ MP imaging system (Bio-Rad, USA).
Niosomes elaboration
The cationic lipid 2,3-di(tetradecyloxy)propan-1-amine used for niosome elaboration was synthesized as previously described by Grijalvo et al. 
Preparation and characterization of the complexes
Analysis of EGFP expression and cell viability
Qualitative expression of EGFP was analyzed using an inverted microscope equipped with an attachment for fluorescent observation (model EclipseTE2000-S, Nikon). 
Colocalization assays
The endocytic processes involved in the internalization of the complexes were analyzed by colocalization assays. NT2 cells were seeded on coverslips (as described for transfection protocol) and co-incubated with the complexes (containing the FITC labeled pCMS-EGFP) and different endocytosis fluorescent markers: AlexaFluor546-Transferrin (50 µg/ml), AlexaFluor555-Cholera toxin (10 µg/ml) or Lysotracker (140 nM), which are markers for clathrin-mediated endocytosis (CME), caveolae/raftmediated endocytosis (CvME) and late endosomal compartment, respectively. After 3 hours of incubation with the complexes, the markers were added to the cells, and they were incubated one more hour. Then, the cells were fixed with formaldehyde 4% and mounted on DAPI fluoromont G for their posterior examination by CLSM.
Colocalization of the green and red signal was analyzed by ImageJ software and quantified by the Mander´s coefficient 33 .
Vulnerability assay of the complexes in the late endosome
As an analogue of the endosomal compartment, anionic micelles based on phosphatidylserine (PS) (Sigma-Aldrich, Spain) were prepared, as described previously 34 . PS was dissolved in chloroform at 1.6 mM and left under magnetic stirring until the solvent was completely evaporated. Phosphate buffer was added to the dried sample, and a dispersed solution was obtained by sonication (Branson Sonifier 250, Danbury).
PS micelles and the complexes were incubated at a w/w ratio of 1:50 (pCMS-EGFP:
PS) for1 hour. After that, the amount of the released DNA from each complex was determined by agarose gel electrophoresis. Naked plasmid or complexes (containing 205 ng pCMS-EGFP) were loaded onto a 0.8 % agarose gel and exposed for 30 min to 100 V. DNA bands were stained with GelRed™ (Biotium, Hayward, California, USA) and images were observed with a ChemiDocTM MP Imaging System (BioRad, Madrid, Spain) and analyzed with Image LabTM software (Bio-Rad, Madrid, Spain).
Statistical analysis
All data are expressed as mean ± SD, n=3. 
RESULTS
Size, PDI and zeta potential of the complexes showed bigger size (294 nm) and PDI (0.44) (Fig. 1A) . The higher polydispersity of the polyplexes can also be observed in the size distribution curve (Fig. 1B) . Regarding the surface charge, it varied from negative to positive values depending on the vector.
Lipoplexes were negatively charged (-29.13 mV) while nioplexes and polyplexes had a positive zeta potential, +35.4 mV and +15.1 mV, respectively (Fig. 1A) . 
NT2 cell viability and EGFP expression
The percentage of viability was determined by flow cytometry at 24, 48 and 72 h postincubation. Cell viability was above 70 % in the three tested formulations at all analyzed times (Fig. 2) , showing minimal differences among the formulations in all tested times. (Fig. 3A) . No statistical differences were observed among the tested times except for lipoplexes; in this case, a significant decrease was observed at 72h (37 %) compared to 24 h (22 %). Among the three formulations, lipoplexes exhibited the highest transfection percentages (up to 35 % at 24 h), and nioplexes the lowest (5 %), while polyplexes were able to transfect almost 20 % of the cells.
Microscopic photographs (Fig. 3B ) corroborated these results, as almost no EGFP positive cells were observed after their transfection with nioplexes (Fig. 3 B6) . A welldefined cell population can be found in flow cytometry dot plots (FSC vs. SSC) in all cases (Fig. 3 C1, C3 , C5, and C7). In FL1 (GFP) vs. FL3 (7-AAD) dots plots, the higher transfection efficiency of lipoplexes (Fig.3 C4) and polyplexes (Fig. 3 C8 ) compared to nioplexes (Fig. 3 C6) and the non-treated cells (Fig. 3 C2) is explicitly represented. In order to show the production of EGFP in the cells, MFI of the transfected cells was calculated ( Fig. 4A) and Western Blot analysis of EGFP expression was performed (Fig. 4B) polyplexes. In this case, a significant increase is observed at 48 hours compared to the previously studied time. In contrast, significant differences were found between the different formulations. Specifically, 24 and 48 hours after transfection, MFI values were significantly higher in lipoplexe-than in nioplexe-transfected cells and significant differences were also detected at 72 hours between nioplexe-and polyplexe-transfected cells (Fig. 4. A) . In addition, Western blot analysis corroborated these results. As seen 
Cellular uptake
The flow cytometry analysis carried out with FITC-labelled pDNA complexes indicated that cellular uptake was clearly time dependent. The percentage of FITC positive cells increased along the time, from 50 % (lipoplexes), almost no uptake (nioplexes) and 20 % (polyplexes) after 1 h of incubation, to 70 % (lipoplexes), 10 % (nioplexes) and 30 % (polyplexes) after 4 h of incubation with the complexes (Fig. 5A) . However, statistical differences were only observed between lipoplexes and nioplexes. In the flow cytometry histogram (Fig. 5B) the uptake of the complexes after four hours of incubation is observed: lipoplexes > polyplexes > nioplexes. Confocal microscope images supported the quantitative results (Fig. 5 C1, C2 , and C3). 
Cell uptake mechanisms
The presence of CME and CvME pathways in NT2 cells was determined with specific markers of endocytic routes, Transferrin-Alexa Fluor and Cholera Toxin-Alexa Fluor, respectively. Flow cytometry histograms ( Fig. 6 A1 and A2 ) illustrated that almost 100 % of NT2 cells were appropriately stained after the treatment with fluorescent markers.
This data indicated that both CME and CvME are present in the studied cell line. Fig. 6B illustrates the confocal images four hours after the co-treatment with the endocytosis markers (red) and lipoplexes /polyplexes (green). Due to the low cellular uptake of nioplexes, this formulation was discarded for uptake mechanism studies.
Colocalization of red and green fluorescence showed visible yellow/orange punctate structures (Fig. 6B ). In addition, we performed a quantitative analysis; the colocalization values were represented as the fraction of complexes colocalized with the fluorescently labelled endocytic structures, represented by the Mander´s (M1) coefficient. The colocalization value of lipoplexes with Transferrin-Alexa Fluor (marker of CME pathway) was higher than the colocalization with Cholera toxin-AlexaFluor (marker of CvME pathway): Mander´s overlap coefficients were 0.471 and 0.367, respectively ( Fig.6 B1 and B2 ). The overlap coefficients were superior for polyplexes, 0.576 with CME marker and 0.697 with CvME marker (Fig.6 B3 and B4 ). 
Intracellular trafficking and endosomal escape
The colocalization of the complexes with the late endosomes at 4 and 6 hours was visualized and quantified by labelling the endosomal compartment with a specific marker: Lysotracker (red colour). Colocalization of red and green fluorescence gave rise to visible yellow/orange punctate structures (Fig. 7A) . The quantitative value was given as the Mander´s overlap coefficient. The results showed that polyplexes were located mainly in the late endosome after 4 hours (M= 0.735), and remained at least until 6 h (M=0.764). The values with lipoplexes were lower at both times (0.543 at 4h and 0.489 at 6h). In Fig. 7 A we observed that at 6 hours, the DNA carried by lipoplexes was located in the nucleus, and even at 4 hours this was evident.
In order to evaluate whether the complexed DNA can be released from the endosomes, we examined the amount of released DNA after mixing the complexes with the previously elaborated PS micelles. The vesicles showed sizes of 170 nm and zeta potential of -65 mV. As observed in the agarose gel (Fig. 7C) , DNA was released from all the complexes after their incubation with PS micelles (Fig. 7B) . 
DISCUSSION
The transfection of the well-established, human NT2 or NT2-N cells is widely employed to obtain suitable platforms for the delivery of exogenous proteins into the CNS 3, 7, 12, 13 . Indeed, the glioma tropism of NT2 cells 9 makes this undifferentiated cell line an interesting tool to derive new cellular vehicles for clinical glioblastoma therapy.
Until now, most of the studies based on genetically engineered NT2 cells rely on the use of viral vectors. However, the development of non-viral transfection strategies to produce stable or transient population of NT2 cells expressing exogenous gene products has distinct advantages, especially if they are subsequently grafted into animals´ models of human nervous system diseases.
The successful design of non-viral carriers for gene delivery requires a profound understanding of the transfection process, which is a complex multi-step process influenced by several factors. The vector is first bound to the cell membrane followed by internalization through an endocytic route. To avoid lysosomal degradation, the genetic material has to be released from the endosomes into the cytoplasm and target the nucleus to start the transcription process and protein synthesis. . The lower zeta potential that we obtained could be explained due to the lower w/w (2:1) that we used to elaborate the lipoplexes. Concerning nioplexes and polyplexes, our previous works supported our current results 25, 28 .
The transfection efficiency of the three vectors and the EGFP production was analyzed along the time. Our findings revealed that negatively charged lipoplexes exhibited the highest transfection efficiencies and protein expression levels [37] [38] [39] , which decreased along the time (Fig. 3 and Fig. 4 ). Lipofectamine is a well-known transfection agent with high transfection efficiency 36 . Although we did not show significant toxicity signs in NT2 cell line with our in vitro viability assay (Fig. 2) , we previously reported the in vitro cytotoxicity of Lipofectamine in other cell lines 25 .Thus, the in vivo application of this reagent has been limited due to its high toxicity compared to other compounds 40 . Our group has previously reported positive results obtained with nioplexes in vitro, ARPE 19 cells, and in vivo 25 .
Surprisingly, nioplexes did not exhibit the expected transfection efficiencies in NT2 cells.
So, we must consider that transfection efficiency is cell line dependent 41 . As an alternative to lipid-based vectors, low molecular weight, and highly deacetylated chitosan have showed promising results 28, 29, 42 . Against all predictions, our results indicated that polyplexes were more efficient for the transfection of NT2 cells than nioplexes. Although the transfection efficiency values were lower than the ones obtained with lipoplexes (15 % versus 35 % at 24 h shown in Fig. 3) , the low toxicity of this polymer enhances its possible clinical applications. Moreover, we should consider that the transfection efficiency of chitosan could be enhanced by its conjugation with several compounds 43 .
In order to understand the differences in the transfection efficiency observed between the vectors, the cellular uptake of the carriers was determined after 1 and 4 hours of incubation (Fig. 5) . The time dependent cellular uptake was already described before by Apaolaza et al.
They reported that the cellular uptake of solid lipid nanoparticles in ARPE19 and HEK293
increased along the time, obtaining the highest results after 8h of incubation 44 . Douglas et al. described that the cellular uptake of alginate-chitosan nanoparticles in 293T, COS7 and CHO cells reached a plateau by 2 h post-treatment 41 . As our transfection experiments were stopped after 4 h of incubation, we decided not to prolong the uptake studies more than 4h results that indicate that the cellular uptake of these nioplexes is almost 100 % in ARPE19 cells. All these data suggest that it is necessary to investigate the behavior of the formulations in every selected cell lines. Overall, the cellular uptake results showed an apparent correlation respect to the corresponding transfection efficiency.
In order to obtain further information about the transfection process of our carriers and considering the different physicochemical characteristic of the studied vectors, we performed colocalization studies to elucidate if the characteristics of the vectors could influence their uptake mechanism and intracellular traffic. Due to the low cellular uptake of nioplexes, these were discarded for the following experiments. Endocytosis has been postulated as the principal mechanism of entry for non-viral vectors. Regarding nanoparticle uptake, CME and CvME are the most common and studied endocytosis routes 47 . By confocal imaging and colocalization assays (Fig. 6) , we concluded that cell entry of lipoplexes (140 nm, -29 mV) occurred mainly through CME, while polyplexes (290 nm, +15 mV) entered the cell mainly by CvME. However, we did not observe radical differences, indicating that both pathways would be involved in the uptake of the two formulations. Although the data reported in the literature regarding the relationship between nanosizes and endocytic pathways is sometimes inconsistent, according to Rejman et al.
internalization of microspheres with diameter < 200 nm involved clathrin-coated pits, while an increase in size provoked a shift of the mechanism that relies on caveolae-mediated endocytosis 48 . Moreover, the internalization process may be also affected by the components of the vectors. The entry of Lipofectamine based lipoplexes by the CME in a myoblast cell line was previously reported by Billiet et al.
36
. Peng et al. described that chitosan/poly(g-glutamic acid) complexes were internalized by macropynocitosis and caveolae-mediated pathway in HT1080 human fibrosarcoma cell line 49 . The major problem of analyzing the effects of the size in the trafficking process is the high polydispersity of many nanomaterials, as it occurs with our chitosan based polyplexes, where large and small particles coexist and different entry pathways may be involved. The surface characteristics of nanoparticles can also influence their internalization mechanisms. Unlike our results, according to the literature, positively charged vectors predominantly internalize through CME, while negatively charged formulations utilize CvME 50 . Nevertheless, exemptions including negatively charted PLGA nanoparticles that enter the cell through caveolaeindependent pathways and PEI based cationic polyplexes that utilize CvME have also been reported in the literature 47, 51 . In addition, we cannot forget that apart from CME and CvME, clathrin-and caveolae-independent endocytosis routes may also take part in the internalization of the nanoparticles 35, 52 . It is worth mentioning that depending on the cell line the internalization pathway of a particular complex could vary. Thus, our results should only be considered for the NT2 cell line.
At 4 hours, the highest colocalization for both lipoplexes and polyplexes was observed in the late endosome ( Fig. 7) being superior with polyplexes, (0.735) compared to lipoplexes (0.543). Particles that enter via CME are confined within endosomes that will suffer a maturation process involving the compartment acidification that results in late endosomes and finally, lysosomes. Although some authors described the CvME as a route away from lysosomal degradation, recently, it has been postulated that the caveosomes are considered to fuse with normal acidified endosomes, allowing the transfer of material to lysosomes 53 .
This hypothesis supports our results since the polyplexes that enter the cell mainly via caveolae-mediated pathways were entrapped in the late-endosomes. In addition, the particle transport mechanism (active transport or diffusion) could define the final fate of the complexes. Particles that are actively transported are usually shuttled from endosomes to lysosomes for degradation 54 . Thus, the next step in the transfection process consists in the endosomal escape of the DNA to avoid lysosomal degradation. Several endosomal escape mechanisms are described in the literature, which vary depending on the nanoparticle 55 . A widely used approach consists of the "proton-sponge effect" which involves nanoparticles having a high buffering capacity, as it is the case of cationic polymers such us PEI. We previously described that UOC posse's higher buffering capacity that high molecular weight chitosans 56 . Another mechanism involves the electrostatic interactions between the nanoparticles and the anionic lipids of the endosome membrane, which causes the destabilization of the endosomal membrane allowing the release of the cargo. As an analogue of the endosomal compartment, we elaborated anionic micelles made from PS, according to Mochizuki´s et al. protocol 34 . As observed in Fig. 7B and 7C, the contact of the vectors with the PS micelles led to the release of the DNA from the particles. This simulated the ability of the studied formulations to release the DNA once they contact the lipid membrane of the endosome, which is a requisite for an efficient transfection.
The velocity of the internalization process could vary depending on the carrier, especially depending on its size 48 . We observed a difference in the internalization velocity of the two studied vectors that could be related to the differences in their size. The colocalization values that we achieved with lipoplexes and the specific markers at 4 h and 6 h were lower compared to the values obtained with polyplexes, which means that at the tested times most of the lipoplexes were not located within the endosomes. Moreover, 6 h after the addition of the particles to the cells, the FITC-labeled DNA carried by lipoplexes was found in the nucleus while the DNA carried by polyplexes was still located within the late endosomes (Fig.7A ). These findings suggested that the internalization process of lipoplexes is a relatively rapid process compared to polyplexes. Rejma et al. described that internalization process of latex beads with 50-100 nm diameter was faster than the process of 200 nm particles 48 .
CONCLUSION
In summary, we have elaborated and characterized three different vectors for pDNA delivery to human neuronal precursor NT2 cells. Their transfection efficiency and cellular uptake were analyzed along the time observing a correlation between both processes. In order to further understand the behavior of the complexes inside the cells, we determined the uptake mechanism of lipoplexes and polyplexes, concluding that they enter the cells mainly via CME and CvME, respectively. Also, at four hours the complexes were localized in the late endosome and were able to release the DNA. Differences in the internalization velocity were observed between lipoplexes and polyplexes. The DNA carried by lipoplexes was localized in the nucleus at six hours while the DNA carried by polyplexes remained in the late endosome. It is hard to draw general conclusions about how to produce complexes with optimal transfection efficiencies. Therefore, it is essential to evaluate and design an appropriate vector for each cell line. According to our results, the cellular uptake of the complexes is a bottleneck in the transfection process of NT2 cells. Overall, this work gives some knowledge about the main aspects that need to be considered for the design and development of novel non-viral vectors to efficiently transfect human neuronal precursor NT2 cells as a first step in the development of a suitable platform for the delivery of exogenous biological agents into the CNS.
